U.K. health secretary Matt Hancock on Monday said a COVID-19 vaccine would “most likely” be available in the first few months of 2021.
“We have got 30 million doses already contracted with AstraZeneca (NYSE:AZN), in fact they are starting to manufacture those doses already, ahead of approval, so that should approval come through, then we are ready to roll out,” Hancock told national news radio station LBC.
AZN has already begun final-stage trial of COVID-19 vaccine in U.S.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.